Then and Now: What We Have Learned From the WHI
Abstract
Context: This narrative review aims to highlight key learning points from the Women's Health Initiative (WHI) studies, providing a nuanced appraisal of menopausal hormone therapy (MHT) risks and benefits in postmenopausal women.
Methods: A structured PubMed search was conducted using MeSH terms and keywords for MHT, bone health, cardiovascular and metabolic disease, cancer (breast, endometrial, ovarian, colorectal), and cognitive outcomes. The search included clinical trials, observational studies, and systematic reviews published in the English language.
Results: WHI data reveal that both combined conjugated equine estrogen-medroxyprogesterone acetate (CEE-MPA) and CEE-only therapy significantly reduce hip, vertebral, and total fracture risk, with further skeletal protection from calcium and vitamin D co-administration. Cardiovascular outcomes are strongly influenced by timing: initiation before age 60 or within 10 years of menopause may confer benefit, while delayed initiation (≥65 years) increases risks of coronary events and stroke, supporting the "window of opportunity" hypothesis. CEE-MPA therapy increases invasive breast cancer incidence (especially in prior users), while estrogen-only therapy is associated with a marginal nonsignificant reduction in breast cancer risk. Both regimens lowered colorectal cancer incidence during active treatment. Early MHT initiation has no effect on cognitive function, whereas late initiation increases dementia risk.
Conclusion: WHI…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.